Annual CFO
-$81.18 M
-$76.06 M-1486.73%
31 December 2023
Summary:
Carisma Therapeutics annual cash flow from operations is currently -$81.18 million, with the most recent change of -$76.06 million (-1486.73%) on 31 December 2023. During the last 3 years, it has fallen by -$54.16 million (-200.52%). CARM annual CFO is now -1486.73% below its all-time high of -$5.12 million, reached on 31 December 2022.CARM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$13.02 M
+$3.10 M+19.23%
30 September 2024
Summary:
Carisma Therapeutics quarterly cash flow from operations is currently -$13.02 million, with the most recent change of +$3.10 million (+19.23%) on 30 September 2024. Over the past year, it has increased by +$7.98 million (+38.00%). CARM quarterly CFO is now -137.63% below its all-time high of $34.60 million, reached on 01 March 2022.CARM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$67.66 M
+$7.98 M+10.55%
30 September 2024
Summary:
Carisma Therapeutics TTM cash flow from operations is currently -$67.66 million, with the most recent change of +$7.98 million (+10.55%) on 30 September 2024. Over the past year, it has increased by +$14.52 million (+17.67%). CARM TTM CFO is now -295.53% below its all-time high of $34.60 million, reached on 01 March 2022.CARM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1486.7% | +38.0% | +17.7% |
| 3 y3 years | -200.5% | - | - |
| 5 y5 years | - | - | - |
CARM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1486.7% | at low | -137.6% | +49.0% | -295.5% | +17.7% |
| 5 y | 5 years | -1486.7% | at low | -137.6% | +49.0% | -295.5% | +17.7% |
| alltime | all time | -1486.7% | at low | -137.6% | +49.0% | -295.5% | +17.7% |
Carisma Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$13.02 M(-19.2%) | -$67.66 M(-10.5%) |
| June 2024 | - | -$16.12 M(-28.1%) | -$75.64 M(-3.1%) |
| Mar 2024 | - | -$22.43 M(+39.3%) | -$78.07 M(-3.8%) |
| Dec 2023 | -$81.18 M | -$16.10 M(-23.3%) | -$81.18 M(-1.2%) |
| Sept 2023 | - | -$21.00 M(+13.2%) | -$82.18 M(+18.2%) |
| June 2023 | - | -$18.55 M(-27.4%) | -$69.50 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$25.53 M(+49.3%) | -$65.25 M(+1175.5%) |
| Dec 2022 | -$5.12 M(-86.3%) | -$17.10 M(+105.5%) | -$5.12 M(-142.7%) |
| Sept 2022 | - | -$8.32 M(-41.8%) | $11.98 M(-41.0%) |
| June 2022 | - | -$14.30 M(-141.3%) | $20.30 M(-41.3%) |
| Mar 2022 | - | $34.60 M | $34.60 M |
| Dec 2021 | -$37.33 M(+38.2%) | - | - |
| Dec 2020 | -$27.01 M | - | - |
FAQ
- What is Carisma Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Carisma Therapeutics?
- What is Carisma Therapeutics annual CFO year-on-year change?
- What is Carisma Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly CFO year-on-year change?
- What is Carisma Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Carisma Therapeutics?
- What is Carisma Therapeutics TTM CFO year-on-year change?
What is Carisma Therapeutics annual cash flow from operations?
The current annual CFO of CARM is -$81.18 M
What is the all time high annual CFO for Carisma Therapeutics?
Carisma Therapeutics all-time high annual cash flow from operations is -$5.12 M
What is Carisma Therapeutics annual CFO year-on-year change?
Over the past year, CARM annual cash flow from operations has changed by -$76.06 M (-1486.73%)
What is Carisma Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CARM is -$13.02 M
What is the all time high quarterly CFO for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly cash flow from operations is $34.60 M
What is Carisma Therapeutics quarterly CFO year-on-year change?
Over the past year, CARM quarterly cash flow from operations has changed by +$7.98 M (+38.00%)
What is Carisma Therapeutics TTM cash flow from operations?
The current TTM CFO of CARM is -$67.66 M
What is the all time high TTM CFO for Carisma Therapeutics?
Carisma Therapeutics all-time high TTM cash flow from operations is $34.60 M
What is Carisma Therapeutics TTM CFO year-on-year change?
Over the past year, CARM TTM cash flow from operations has changed by +$14.52 M (+17.67%)